Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INZY | FATE | TRDA | ||
| Company | Inozyme Pharma Inc | Fate Therapeutics | Entrada Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.00 | 2.28 | 6.61 | ||
| High | 4.00 | 2.31 | 6.84 | ||
| Low | 3.99 | 2.10 | 6.33 | ||
| Latest | 4.00 | 2.12 | 6.47 | ||
| Change | +0.01 | -0.13 | -0.09 | ||
| % Change | +0.25% | -5.78% | -1.37% | ||
| Volume | 1,459,400 | 2,202,783 | 274,681 | ||
| 20-Day Average Volume | 1,079,340 | 4,052,446 | 698,066 | ||
| Previous Close | 3.99 | 2.25 | 6.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.99 | 1.94 | 9.32 | ||
| 20-Day Raw Stochastic | 100.00% | 75.90% | 7.02% | ||
| 20-Day Relative Strength | 81.11 | 60.71 | 33.58 | ||
| Weighted Alpha | -60.68 | +32.30 | +34.66 | ||
| Today's Opinion | 88% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 80% Buy | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 40% Buy | 88% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.25% since 06/23/25 | +25.14% since 05/18/26 | +8.49% since 05/18/26 | ||
| Low | 3.99 on 06/30/25 | 1.59 on 05/19/26 | 5.63 on 05/19/26 | ||
| High | 4.00 on 06/30/25 | 2.32 on 05/22/26 | 6.84 on 05/26/26 | ||
| 1-Month | |||||
| %Chg | +0.76% since 05/30/25 | +62.78% since 04/24/26 | -49.41% since 04/24/26 | ||
| Low | 3.96 on 06/02/25 | 1.22 on 04/30/26 | 5.63 on 05/19/26 | ||
| High | 4.00 on 06/30/25 | 2.46 on 05/08/26 | 16.45 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +334.69% since 03/28/25 | +38.78% since 02/26/26 | -50.04% since 02/26/26 | ||
| Low | 0.72 on 04/07/25 | 1.04 on 03/19/26 | 5.63 on 05/19/26 | ||
| High | 4.00 on 06/30/25 | 2.46 on 05/08/26 | 16.45 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | +41.84% since 12/30/24 | +96.82% since 11/26/25 | -36.61% since 11/26/25 | ||
| Low | 0.72 on 04/07/25 | 0.95 on 12/23/25 | 5.63 on 05/19/26 | ||
| High | 4.00 on 06/30/25 | 2.46 on 05/08/26 | 16.45 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 258,248 | 262,258 | 254,666 | ||
| Shares Outstanding, K | 64,562 | 116,559 | 38,821 | ||
| Annual Sales | 0 | 6,650,000 | 25,420,000 | ||
| Annual Net Income | -102,020,000 | -136,320,000 | -143,750,000 | ||
| Last Quarter Sales | 0 | 1,300,000 | 880,000 | ||
| Last Quarter Net Income | -28,040,000 | -31,210,000 | -39,720,000 | ||
| 60-Month Beta | 2.27 | 2.13 | -0.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 05/14/25 | -0.26 on 05/13/26 | -0.95 on 05/07/26 | ||
| Earnings Date | 08/05/25 | 08/11/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||